The Government of Canada is making a major push into genomics, investing $175.1 million to turn cutting-edge research into real-world breakthroughs in healthcare, agriculture, and clean technology.
Yasir Naqvi, Parliamentary Secretary to the Minister of Health, announced the launch of the Canadian Genomics Strategy on behalf of Minister of Innovation, Science and Industry François-Philippe Champagne. The initiative spans seven years, starting in 2024, and aims to position Canada as a leader in this rapidly evolving field.
Bridging research and commercialization
The strategy is designed to help translate cutting-edge genomics research into real-world applications across key sectors. In healthcare, this includes advancements in personalized medicine, advanced diagnostics and novel therapeutics — including next-generation vaccines — and treatments for conditions such as cancer and rare diseases.
In agriculture, genomics is expected to support food security by enhancing crop resilience and livestock health.
The strategy also focuses on clean technology, with applications such as biofuels and bioremediation techniques that could help reduce pollution and environmental impact. By fostering collaboration between researchers, businesses, and institutions, the initiative will stimulate commercialization, improve access to genomics data, and strengthen Canada’s talent pipeline in the bioeconomy.
Positioning Canada as a global genomics leader
“Today’s launch of the Canadian Genomics Strategy will help solidify Canada’s position as a global leader in genomics innovation and place our talented researchers, innovators and businesses at the forefront of this cutting-edge work,” said Champagne.
“By investing in the commercialization of genomics technologies, our government is securing a healthier and more prosperous future for Canadians for generations to come.”
Naqvi echoed this sentiment, highlighting the economic benefits of genomics investment.
“Investing in genomics innovation is essential to driving economic growth and delivering real benefits for Canadians,” he explained.
“Through the Canadian Genomics Strategy, we are advancing commercialization, fostering collaboration and developing a highly skilled workforce to ensure Canada remains at the forefront of this rapidly evolving field.”
A coordinated national effort
The strategy builds on initiatives announced in Budget 2021 and is led by Innovation, Science and Economic Development Canada, the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council of Canada. Genome Canada, a key partner in the initiative, will help coordinate efforts to enhance Canada’s genomics ecosystem and address workforce gaps in the sector.
By supporting both innovation and commercialization, the federal government aims to leverage Canada’s existing strengths in genomics research while driving economic growth and addressing global challenges in health, agriculture, and environmental sustainability.
This article was created with the assistance of AI. Learn more about our AI ethics policy here.
